Skip to content

Advances in Motion

#AHA18 on Twitter: New Cholesterol Guidelines, the PIONEER-HF Trial and More

Article

In This Article

  • Health care professionals at this year's #AHA18 talked research, treatment approaches and guidelines on the podium and in conference halls
  • These conversations continued on Twitter, with thousands of #AHA18 tweets
  • Highlights include the updated cholesterol guidelines, PIONEER-HF and REDUCE-IT

Health care professionals at this year’s American Heart Association's Scientific Sessions discussed late-breaking research, innovative treatment approaches and new patient care guidelines. The conversations carried over from the podium and conference halls onto Twitter, with thousands of tweets, according to Symplur. Trending topics included the updated cholesterol guidelines and outcomes of both the REDUCE-IT and PIONEER-HF trials.

Here is a list of some noteworthy #AHA18 tweets.

New Cholesterol Guidelines

Pradeep Natarajan, MD, MMSc, director of Preventive Cardiology, shared his 60-second take on the newly released AHA/ACC Cholesterol Guidelines.

 

 

REDUCE-IT Trial

Results presented from the REDUCE-IT trial show cardiovascular risk reduction with icosapent ethyl, the first Pure EPA prescription Omega-3.

 

 

Sawallah Guseh, MD, Wins Laennec Young Clinician Award

Mass General's own Sawallah Guseh, MD, cardiology fellow, received the Laennec Young Clinician Award, which recognizes the importance of clinical accumen, inductive analytic skills and teaching ability in future academic cardiologists.

 

 

Exercise and Regenerative Heart Activity

Anthony Rosenzweig, MD, chief of Cardiology, shared his expertise on the relationship between exercise and regenerative heart activity.

 

 

PIONEER-HF Trial

James Januzzi, MD, Hutter Family Professor of Medicine, shares what he believes to be the most important aspect of PIONEER-HF.

 

 

Robert Levine: AHA Distinguished Scientist

Mass General's own Robert Levine, MD, senior physician, was was honored as an AHA Distinguished Scientist for his contribution to cardiovascular and stroke research.

Mechanism Linking Noise Exposure to Metabolic Disease

Ahmed Tawakol, MD, co-director of the Cardiac MR PET CT Program, and Michael Osborne, MD, presented preliminary research that found a novel mechanism between exposure to noise and metabolic disease.

Do you use Twitter to disseminate innovative treatment approaches and new data? Tell us about your experience with social media as a platform for discussing research in the comments below.

Refer a patient to the Mass General Heart Center

Learn more about Mass General at #AHA18

Related topics

Related

From machine learning to metabolic disease, the topics discussed and presented by Mass General clinicians and researchers at #2018 foster a dialogue that contributes to the transformation of cardiovascular care in the practice setting and the improvement of heart health for patients.

Cardiovascular, Coronary Artery Disease

Article

Related

20 years ago, Sekar Kathiresan asked the question “Why do patients have a heart attack at a young age?” Watch him discuss his journey to answering that question, and how it led him to becoming an AHA Distinguished Scientist.

Cardiovascular, Coronary Artery Disease

Video